VDB
CVE-2023-21925
CVE-2023-21925
PUBLISHED
Health Sciences Applications ist eine Zusammenstellung von Produkten für die Pharma-, Biotechnologie-, Medizin- und Gesundheitsbranche.
EPSS 0.63% · 49.4th percentile
Risk Scores
EPSS Score
0.63%
49.4th percentile
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Oracle | Oracle Health Sciences Applications <7.0.0.1 | |
| Oracle | Oracle Health Sciences Applications 5.4.0.2 | |
| Oracle | Oracle Health Sciences Applications <8.2.3 | |
| Oracle | Oracle Health Sciences Applications <6.3.1.3 |
Timeline
- Apr 18, 2023 CVE Published
- Apr 19, 2023 EPSS Score
- May 27, 2023 EPSS Score
- Jul 5, 2023 EPSS Score
- Aug 12, 2023 EPSS Score
- Sep 19, 2023 EPSS Score
- Oct 28, 2023 EPSS Score
- Dec 5, 2023 EPSS Score
- Jan 12, 2024 EPSS Score
- Feb 20, 2024 EPSS Score
- Mar 29, 2024 EPSS Score
- May 6, 2024 EPSS Score
References
- https://wid.cert-bund.de/.well-known/csaf/white/2023/wid-sec-w-2023-1015.json advisory
- https://www.esentire.com/blog/threat-actors-use-cve-2019-18935-to-deliver-reverse-shells-and-juicypotatong-privilege-escalation-tool advisory
- https://github.com/alanbarret/CVE-2019-18935 advisory
- https://wid.cert-bund.de/portal/wid/securityadvisory?name=WID-SEC-2023-1015 advisory
- https://www.oracle.com/security-alerts/cpuapr2023.html#AppendixHCAR advisory